PROVIDER PROFILE · NPI 1003077355

Angela SedaM.D.

PRACTICEONCOLOGY PHARMACY SERVICES, INCSee all providers at this practice →

Surgical OncologyArlington, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

289

Unique beneficiaries

—

Total services

303

Distinct HCPCS

Medicare payment

$53K

Peer benchmark

Total Medicare services vs. 135 Surgical Oncology providers in TX — above median (cohort median 261).

PRESCRIBING · PART D · 2024

Total Rx claims

120

Beneficiaries

—

Total drug cost

$938

Distinct drugs

Brand share

100.0%

Top prescribed drugs

Acetaminophen With Codeine71 claims

Hydrocodone/Acetaminophen37 claims

Sulfamethoxazole/Trimethoprim12 claims

QUALITY · MIPS · 2024

Final MIPS score

85.1

Quality

67.5

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.43%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$93

Payment records

By payment type

Food and Beverage$93

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (5)

Hospital

Hospital

Hospital

Hospital

Hospital

REFERRAL NETWORK

Where Angela Seda's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
TEXAS HEALTH ARLINGTON MEMORIAL HOSPITAL	20	59
Tilden Childs Diagnostic Radiology · Fort Worth, TX	13	37

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
TEXAS HEALTH ARLINGTON MEMORIAL HOSPITAL	21	76

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history